FDA/CDC

CDC shortens COVID-19 quarantine time to 10 or 7 days, with conditions


 

Home for the holidays

Similar to its pre-Thanksgiving advisory, the CDC also recommends people avoid travel during the upcoming winter holidays. “The best way to protect yourself and others is to postpone travel and stay home,” Dr. Walke said.

If people do decide to travel, the agency recommends COVID-19 testing 1-3 days prior to travel and again 3-5 days afterward, as well as reducing nonessential activities for a full 7 days after returning home. Furthermore, if someone does not have follow-up testing, the CDC recommends reducing nonessential activities for 10 days.

Testing does not eliminate all risk, Dr. Walke said, “but when combined with reducing nonessential activities, symptom screening and continuing with precautions like wearing masks, social distancing and hand washing, it can make travel safer.”

“We are trying to reduce the number of infections by postponing travel over the winter holiday,” Cindy Friedman, MD, chief of the CDC Travelers’ Health Branch, said during the media briefing.

“Travel volume was high during Thanksgiving,” she said, “and even if only a small percentage of those travelers were asymptomatically infected, this can translate into hundreds of thousands of additional infections moving from one community to another.”

This article first appeared on Medscape.com.

Pages

Recommended Reading

Pfizer files for FDA emergency use authorization of COVID vaccine
MDedge Dermatology
AMA takes on vaccine misinformation, physician vaccines, racism
MDedge Dermatology
COVID-19 cases in children continue to set records
MDedge Dermatology
CDC panel delves into priorities for COVID vaccine distribution
MDedge Dermatology
Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest
MDedge Dermatology
Approval of COVID-19 vaccines will change nature of clinical trials
MDedge Dermatology
Blood glucose on admission predicts COVID-19 severity in all
MDedge Dermatology
Moderna filing for FDA emergency COVID-19 vaccine approval, reports 94.1% efficacy
MDedge Dermatology
Are more female physicians leaving medicine as pandemic surges?
MDedge Dermatology
ACIP: Health workers, long-term care residents first tier for COVID-19 vaccine
MDedge Dermatology